What was the TLF rate for DCB in the AGENT IDE trial?

Unlock all questions

This demo includes only 20 questions. Upgrade to access hundreds of questions, flashcards, exam simulations, and disable ads.

Full question bankExam simulationsFlashcards
From $24.99Unlock all

Practice for Clinical Training 1 (CT1) Day 4 Exam. Enhance your skills with a range of questions designed to test your clinical knowledge. Each question features detailed explanations to help you succeed.

Multiple Choice

What was the TLF rate for DCB in the AGENT IDE trial?

Explanation:
In the context of the AGENT IDE trial, the TLF (target lesion failure) rate for drug-coated balloons (DCB) is documented to be 17.9%. This value is significant as it reflects the efficacy of DCBs in treating the target lesion, indicating both the safety and effectiveness of the device in achieving clinical success. The TLF rate is a critical endpoint in clinical trials, providing insight into the performance of the treatment in preventing adverse outcomes following the procedure. Knowing the specific TLF rate helps clinicians assess the relative risks and benefits associated with the use of DCBs in their practice.

In the context of the AGENT IDE trial, the TLF (target lesion failure) rate for drug-coated balloons (DCB) is documented to be 17.9%. This value is significant as it reflects the efficacy of DCBs in treating the target lesion, indicating both the safety and effectiveness of the device in achieving clinical success. The TLF rate is a critical endpoint in clinical trials, providing insight into the performance of the treatment in preventing adverse outcomes following the procedure. Knowing the specific TLF rate helps clinicians assess the relative risks and benefits associated with the use of DCBs in their practice.

More Multiple Choice Questions
Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy